Is Nu Skin Enterprises Inc (NUS) overvalued? · P/E 4.9, rev $1.73B
Nu Skin Enterprises Inc (NUS) is a household & personal products company listed on US.
This page asks whether Nu Skin Enterprises Inc (NUS) looks expensive on cached numbers — not a short thesis.
Latest reported NUS revenue for 2024-12-31 was $1.73B. Net income was -$146.6M. Revenue was down 12.0% from 2023-12-31 to 2024-12-31. NUS currently screens at market cap $258.3M and trailing P/E 4.9.
NUS currently screens at market cap $258.3M and trailing P/E 4.9. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next NUS 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the NUS stock page for the full model, not this heading.
Not investment advice.